In FLT3-mutant AML, C/EBPα cooperates with FLT3 signaling to boost lipid anabolism, whereas loss of either C/EBPα or FLT3 reduces MUFA incorporation into membrane phospholipids by suppressing SCD expression. Here, CEBPA is linked to acute myeloid leukemia.